Sign In
Buy OCUL
$8.35
+0.0400 (+0.481%)
At Close: Jun 03, 2026
Ocular Therapeutix Inc (NASDAQ:OCUL) Given Average Recommendation of "Buy" by Analysts
05:56am, Thursday, 09'th Apr 2020
Ocular Therapeutix Inc (NASDAQ:OCUL) has received a consensus recommendation of “Buy” from the ten analysts that are covering the company, Marketbeat Ratings reports. Two research analysts have ra
Man Group plc Has $3 Million Stake in Ocular Therapeutix Inc (NASDAQ:OCUL)
11:12am, Tuesday, 07'th Apr 2020
Man Group plc cut its stake in Ocular Therapeutix Inc (NASDAQ:OCUL) by 60.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC)
Ocular Therapeutix (NASDAQ:OCUL) Stock Price Up 7.7%
09:54am, Tuesday, 07'th Apr 2020
Ocular Therapeutix Inc (NASDAQ:OCUL) rose 7.7% during mid-day trading on Monday . The company traded as high as $5.25 and last traded at $5.15, approximately 556,048 shares traded hands during mid-day
Daily Insider Ratings Round-Up 3/24/20
04:42pm, Thursday, 26'th Mar 2020
Tables of the top insider purchases and sales filed with the SEC on 3/24/20, based on dollar value. Dollar values often do not equate with significance when it
Daily Insider Ratings Round Up + Daily Ratings Report For 3/20/20
05:35pm, Sunday, 22'nd Mar 2020
We're augmenting our usual tables of top 10 dollar value insider purchases and sales filed with the SEC on 3/20/20, with our full Daily Ratings Report for the s
Daily Insider Ratings Round Up 3/17/20
11:50pm, Wednesday, 18'th Mar 2020
Tables of the top insider purchases and sales filed with the SEC on 3/17/20, based on dollar value. Dollar values often do not equate with significance when it
BMO likes Blueprint Medicines in premarket analyst action
11:31am, Tuesday, 17'th Mar 2020
Arrowhead Pharmaceuticals (NASDAQ:ARWR) initiated with Neutral rating and $45 (107% upside) price target at Goldman Sachs.Ocular Therapeutics (NASDAQ:OCUL) initiated with Buy rating and $8 (97% upside
Jefferies Initiates Coverage On Ocular Therapeutix with Buy Rating, Announces $8 Price Target
12:00am, Tuesday, 17'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dum
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Earnings Scheduled For March 12, 2020
08:51am, Thursday, 12'th Mar 2020
Companies Reporting Before The Bell Dollar General Corporation (NYSE: DG ) is projected to report quarterly earnings at $2.02 per share on revenue of $7.15 billion. Genesco Inc. (NYSE: GCO ) is estima
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
